Clinical Trial Update: A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension [Phase 4]

View source ↗

Summary

Phase 4 multicenter study evaluating methods to reduce hyperemia associated with bimatoprost therapy for glaucoma and ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Bimatoprost (bimatoprost)

Snippet

Sponsor: Innovative Medical | Conditions: Glaucoma | Phase 4 | Status: COMPLETED